COPE: COVID-19 Antibody Testing of Patients with ESRD
What is the COPE Study?The outbreak of COVID-19 has quickly changed the world and has affected everyone. The COPE Study is a research study to test for the presence of COVID-19 antibodies in patients with ESRD to help us improve our knowledge and understanding of the disease and to determine the impact of the disease on psychological and social behaviors.
What do I have to do to participate?1. Give consent to be a part of the study.
2. Complete a brief survey that will ask you about your medical history, knowledge and concerns about COVID-19, social distancing practices, and other questions that will help us understand how the disease has affected you.
3. Receive a testing kit in the mail to provide a sample of your blood and return the sample to Johns Hopkins for testing.
4. Be available for future contact so we may inform you of your test results.
What are the benefits to participation?We hope that the results of this study will be used to improve the prevention and control of the disease, find future treatments, and improve the quality of care for patients with ESRD.
Am I eligible to participate?To be eligible to participate in our study, you must be:
1. At least 18 years old
2. English speaking
3. Receiving in-center maintenance hemodialysis
4. Planning to receive the vaccine for COVID-19 when it becomes available.
If I do not like the study, can I stop?Yes, you can stop the study at any time.
If I do not participate, will it affect my care?No, you will receive the same care whether or not you participate in this study.
Where can I get more information?If you would like more information about the COPE Study, please contact us at:
Protocol Number: IRB00249848